Labelling error in blood pressure medicine: Patient asked to contact pharmacist or GP urgently

Labelling error in blood pressure medicine: Patient asked to contact pharmacist or GP urgently The Medicines and Healthcare products Regulatory Agency (MHRA) has issued an urgent alert following a labelling error on a batch of the common blood pressure medicine lercanidipine (lercanidipine hydrochloride). The alert comes after Recordati Pharmaceuticals Limited, the manufacturer, informed the MHRA of an error in the strength of the product printed on some sides of the product carton for one batch. “The packs are incorrectly labelled as 10mg on some sides of the pack when they are 20mg tablets. The correct strength (20mg) is printed on the top of the carton and on the blister strips.” The error is limited to batch number MD4L07, with an expiry date of 01/2028. Patients who take lercanidipine are advised to immediately check the batch number printed on the foil of the blister strips.